Calvin Sandra Insider Trades

Insider Trading History

Track insider trading activity for Calvin Sandra. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Travere Therapeutics
Travere Therapeutics TVTX
Svp, CHIEF ACCOUNTING OFFICER
Holding Value $1.91M 42,353 shares
Last Trade
Apr 14, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$903k 21,977 shares
$41.07
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
Svp, CHIEF ACCOUNTING OFFICER
Holding Value $2.91M 64,330 shares
Last Trade
Apr 14, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$642k 15,250 shares
$42.13
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
Svp, CHIEF ACCOUNTING OFFICER
Holding Value $881k 19,500 shares
Last Trade
Apr 14, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$642k 15,250 shares
$42.13
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
Svp, CHIEF ACCOUNTING OFFICER
Holding Value $2.22M 49,080 shares
Last Trade
Feb 03, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$139k 4,333 shares
$32.12
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
Svp, CHIEF ACCOUNTING OFFICER
Holding Value $2.41M 53,413 shares
Last Trade
Jan 31, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.1M 35,340 shares
$31.09
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
Svp, CHIEF ACCOUNTING OFFICER
Holding Value $1.73M 38,233 shares
Last Trade
Dec 24, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$296k 7,402 shares
$40.00
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
Svp, CHIEF ACCOUNTING OFFICER
Holding Value $2.06M 45,635 shares
Last Trade
Dec 15, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$105k 2,910 shares
$36.00
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
Svp, CHIEF ACCOUNTING OFFICER
Holding Value $848k 18,750 shares
Last Trade
Nov 04, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.09M 61,250 shares
$34.13
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
Svp, CHIEF ACCOUNTING OFFICER
Holding Value $5.23M 115,660 shares
Last Trade
Nov 04, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.09M 61,250 shares
$34.13
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
Svp, CHIEF ACCOUNTING OFFICER
Holding Value $2.19M 48,545 shares
Last Trade
Nov 04, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.42M 67,115 shares
$36.00
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
Svp, CHIEF ACCOUNTING OFFICER
Holding Value $3.56M 78,654 shares
Last Trade
Feb 11, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$594k 25,000 shares
$23.75
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
Svp, CHIEF ACCOUNTING OFFICER
Holding Value $2.88M 63,654 shares
Last Trade
Feb 03, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$67.4k 3,348 shares
$20.12
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
Svp, CHIEF ACCOUNTING OFFICER
Holding Value $3.03M 67,002 shares
Last Trade
Jan 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$532k 26,000 shares
$20.46
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
Svp, CHIEF ACCOUNTING OFFICER
Holding Value $2.44M 54,002 shares
Last Trade
Jan 22, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$17.5k 925 shares
$18.94
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
Svp, CHIEF ACCOUNTING OFFICER
Holding Value $3.16M 69,927 shares
Last Trade
Dec 26, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$267k 15,000 shares
$17.78
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
Svp, CHIEF ACCOUNTING OFFICER
Holding Value $0 0 shares
Last Trade
Dec 26, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$267k 15,000 shares
$17.78
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
Svp, CHIEF ACCOUNTING OFFICER
Holding Value $2.48M 54,927 shares
Last Trade
Dec 26, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$258k 15,000 shares
$17.22
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
Svp, CHIEF ACCOUNTING OFFICER
Holding Value $678k 15,000 shares
Last Trade
Nov 25, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$273k 15,000 shares
$18.18
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
Svp, CHIEF ACCOUNTING OFFICER
Holding Value $3.03M 67,017 shares
Last Trade
Nov 25, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$273k 15,000 shares
$18.18
$45.20
Travere Therapeutics
Travere Therapeutics TVTX
Svp, CHIEF ACCOUNTING OFFICER
Holding Value $2.48M 54,927 shares
Last Trade
Nov 25, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$221k 12,090 shares
$18.30
$45.20

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up